Biopsy
A biopsy is the removal of a tissue or cell sample for examination under a microscope — the only method that gives a definitive histopathological diagnosis for lesions whose nature can't be settled by imaging alone. It covers a broad family of techniques, from a thin needle to a surgical procedure, chosen individually based on the location and type of the suspected lesion.
Number of studies
2
Safety
Requires caution
Time to effects
Not applicable — biopsy is a diagnostic procedure, not a therapeutic intervention.
Who it's for
Table of contents
TL;DR
A biopsy is the removal of a tissue or cell sample for examination under a microscope — the only method that gives a definitive histopathological diagnosis for lesions whose nature can't be settled by imaging alone. It covers a broad family of techniques, from a thin needle to a surgical procedure, chosen individually based on the location and type of the suspected lesion.
- →The only method that gives a definitive histopathological diagnosis, distinguishing a benign lesion from a malignant one
- →Enables determination of the subtype, degree of differentiation, and molecular features of a lesion, key to choosing treatment
- →Helps patients with benign lesions avoid unnecessary surgery
| Test type | Collection of tissue or cells for histopathological/cytological evaluation under a microscope |
|---|---|
| Level of evidence | Strong — the gold standard for histopathological diagnosis of tumors and many organ diseases |
| Target group | People with a suspicious lesion on imaging or abnormal results suggesting disease of a specific organ |
| Material collected | Individual cells (FNA) or a core/fragment of tissue preserving architecture (core-needle, excisional biopsy) |
| Turnaround time | Usually a few days for a standard evaluation, up to 2–3 weeks with immunohistochemical and molecular testing |
| Status | Invasive procedure, usually outpatient, performed under local anesthesia |
Understand
Overview
A biopsy is a diagnostic procedure that removes a small fragment of tissue or a group of cells from a suspicious lesion for examination under a microscope by a pathologist. Unlike imaging tests, which show only the shape, size, and structure of a lesion, a biopsy provides information about its actual cellular makeup — it answers whether a lesion is benign, malignant, inflammatory, or infectious, and is the only method that gives a definitive, conclusive histopathological diagnosis in the vast majority of cancers and many diseases of solid organs.
The clinical significance of a biopsy goes far beyond simply confirming or ruling out a malignancy. Tissue material allows the histological subtype of a lesion to be determined, its degree of differentiation (grade), and — thanks to immunohistochemical and molecular techniques — also its receptor and genetic profile, which today directly determines the choice of targeted therapy, for example in breast, lung, or lymphoid cancers. No imaging test, however advanced, can provide this level of information — imaging shows where a lesion is and how large it is, while a biopsy answers what that lesion actually is at the cellular level.
Biopsies are ordered in very different clinical contexts. Most commonly it's a suspicious focal lesion found on imaging — a lump in the breast, lung, thyroid, or a lymph node — requiring a histopathological answer before treatment decisions can be made. A second large group of indications is abnormal lab results suggesting disease of a specific organ — chronically elevated liver enzymes unexplained by non-invasive workup, abnormal blood counts suggesting bone marrow disease, or an elevated PSA level after an inconclusive prostate MRI. A third group is skin lesions raising suspicion of melanoma or another skin cancer, where a biopsy is often both a diagnostic procedure and the first step of treatment.
On the practical side, most biopsies are outpatient procedures performed under local anesthesia, lasting anywhere from a few minutes to about an hour, after which the patient usually goes home the same day. Preparation depends on the technique and location — most often it involves stopping anticoagulant and antiplatelet medications a few days before the procedure after consulting the treating physician, and for some procedures (e.g., biopsies of abdominal organs), fasting. The collected material goes to a pathology lab, where it undergoes fixation, paraffin embedding, sectioning, and staining — a standard result is usually available after a few days, while additional testing (immunohistochemistry, molecular tests) can extend the wait to two or three weeks.
A number of misconceptions have grown up around biopsies that are worth dispelling. Some patients worry that puncturing a tumor spreads cancer cells throughout the body — the risk of this phenomenon (so-called needle-tract seeding) is very low with modern coaxial techniques and, based on available data, doesn't meaningfully worsen prognosis in the vast majority of clinical situations. Another misconception is the belief that a normal imaging result makes a biopsy unnecessary — imaging and histopathology answer entirely different questions and in many situations are complementary rather than interchangeable.
The choice of a specific biopsy technique depends on the location of the lesion, its accessibility, size, and the clinical question the result needs to answer — from a thin aspiration needle collecting individual cells, through a thicker core needle preserving tissue architecture, to a surgical procedure removing all or part of a lesion. Biopsies are increasingly performed under imaging guidance (ultrasound, CT, mammographic stereotaxis), which allows even non-palpable, deep-seated lesions to be precisely targeted.
Biopsy remains the gold standard of histopathological diagnosis and the starting point for most oncology decisions, despite the rapid development of non-invasive alternatives such as liquid biopsy or advanced imaging. Its value lies not only in confirming the presence of disease, but above all in precisely characterizing its biology — information without which modern, personalized cancer treatment simply wouldn't be possible.
Mechanism of action
The fundamental goal of any biopsy is to obtain a sufficient amount of viable, well-preserved tissue so the pathologist can assess not just individual cells but, wherever possible, the tissue architecture — how cells are arranged relative to each other and the surrounding matrix. This distinction is crucial: cytological evaluation alone (individual cells on a smear) can identify features of malignancy at the cellular level but is often insufficient to determine the histological tumor type or degree of invasion, which requires the preserved tissue structure obtained via a core-needle or surgical biopsy.
Needle-based techniques differ mainly in needle thickness and the amount of material collected. Fine-needle aspiration (FNA) uses a very thin needle (usually 22–25G) to aspirate a small number of cells, which are smeared onto a slide and evaluated cytologically — it's fast, minimally invasive, and carries minimal complication risk, but is limited by its lack of tissue-architecture assessment. Core-needle biopsy uses a thicker, often spring-loaded cutting needle (usually 14–18G) that removes a cylindrical core of tissue several millimeters to a few centimeters long, preserving tissue structure and enabling a full histopathological evaluation along with additional testing.
Most modern biopsies of internal organs are performed under real-time imaging guidance — most often ultrasound, given its availability and lack of radiation, less often CT for lesions hard to see on ultrasound (e.g., in the lungs), or mammographic stereotaxis for microcalcifications in the breast invisible on ultrasound. Imaging allows the operator to track the needle's trajectory in real time and precisely hit the target lesion, minimizing the number of insertions and the risk of damaging nearby structures such as major blood vessels or nerves.
Surgical and endoscopic biopsies form a separate category. An excisional biopsy removes the entire lesion along with a margin of healthy tissue and can be both a diagnostic and a therapeutic procedure; an incisional biopsy removes only a fragment of a larger lesion; and an endoscopic biopsy uses forceps passed through the working channel of an endoscope to collect mucosal samples during colonoscopy or gastroscopy. A separate, highly specialized procedure is bone marrow biopsy, combining aspiration of liquid marrow with a trephine biopsy — a bone core taken from the iliac crest — evaluated together in the diagnosis of hematological diseases.
After collection, the material goes to the pathology lab, where it undergoes a standardized process: fixation in formalin to halt cellular autolysis, dehydration and embedding in paraffin, cutting into very thin sections with a microtome, and then staining (most often hematoxylin and eosin) to reveal cellular structures under a light microscope. In cases requiring deeper characterization, immunohistochemical stains are additionally performed to detect the presence of specific proteins (e.g., hormone receptors) on or inside cells, along with molecular tests identifying genetic mutations relevant to prognosis and the choice of targeted therapy.
Choice of method and lesion location
Based on prior imaging, the biopsy technique and needle-guidance approach (ultrasound, CT, stereotaxis) are chosen to fit the lesion's location and nature.
Collecting the material
An aspiration needle, core needle, or surgical instrument collects cells or a tissue fragment from the target lesion, usually under real-time imaging guidance.
Fixation and histopathological processing
The material is fixed in formalin, dehydrated, embedded in paraffin, cut into thin sections, and stained, revealing cellular structure under the microscope.
Microscopic evaluation and additional testing
The pathologist evaluates the specimen under the microscope and, if needed, orders immunohistochemical stains and molecular tests to further characterize the lesion.
Evidence: strong — based on 2 studies in this database.
Benefits
Common myths
MythA biopsy spreads cancer cells throughout the body.
FactThe risk of needle-tract seeding exists, but with modern coaxial techniques it's very low and in most clinical situations doesn't meaningfully worsen prognosis — the benefit of obtaining a diagnosis usually far outweighs this risk.
MythA normal imaging result makes a biopsy unnecessary.
FactImaging assesses the shape, size, and structure of a lesion, while a biopsy assesses its actual cellular makeup — these are two complementary, not interchangeable, sources of information.
MythA biopsy is always major surgery requiring general anesthesia.
FactThe vast majority of biopsies are short outpatient procedures performed under local anesthesia, after which the patient goes home the same day.
MythA negative biopsy result always fully rules out cancer.
FactSampling error is possible, especially in heterogeneous lesions — which is why a result inconsistent with the clinical or radiological picture requires repeating the biopsy or further workup.
Forms & variants
Biopsy comes in several forms that differ in bioavailability and use case — the form you pick genuinely matters for how effective the supplementation is.
Fine-needle aspiration (FNA)
A thin needle aspirating individual cells for cytological evaluation.
Best for: Fast initial evaluation of superficial lesions and lymph nodes
Core-needle biopsy
A thicker cutting needle collecting a tissue core with preserved architecture.
Best for: Lesions in the breast, prostate, liver, or lungs requiring a full histopathological evaluation
Excisional/incisional biopsy
Surgical removal of an entire lesion or a fragment of it.
Best for: Skin lesions, lymph nodes, cases inconclusive after a needle biopsy
Image-guided biopsy (ultrasound/CT/stereotaxis)
Precise real-time needle guidance.
Best for: Non-palpable, deep-seated lesions
Endoscopic (forceps) biopsy
Collecting a mucosal sample during an endoscopy.
Best for: Gastrointestinal lesions found during colonoscopy or gastroscopy
Bone marrow biopsy
Aspiration and trephine biopsy of the iliac crest.
Best for: Diagnosing hematological diseases and blood-count abnormalities
Check your profile
Not sure which supplements actually make sense for you?
Answer a few short questions about your lifestyle, diet, sleep, and goals. VitMode will build your profile and show supplements worth considering — with reasoning and evidence strength.
Recommendations take your answers and the strength of the scientific evidence into account. A supplement's popularity has no bearing on whether it gets recommended.
Practice
Frequently asked questions
Most biopsies are performed under local anesthesia, so the procedure itself is usually felt as pressure rather than sharp pain. Discomfort and tenderness at the puncture site can last a few days after the procedure.
A standard histopathological evaluation is usually ready after a few days. If additional immunohistochemical or molecular testing is needed, the wait can extend to two or three weeks.
This most often involves temporarily stopping anticoagulant and antiplatelet medications after consulting the treating physician, and for some procedures, fasting. Specific recommendations depend on the location and technique of the biopsy.
Fine-needle aspiration collects individual cells for cytological evaluation and is less invasive, but has limited diagnostic value. Core-needle biopsy collects a tissue fragment with preserved architecture, allowing a fuller histopathological evaluation.
Not always — sampling error is possible, especially in heterogeneous lesions. If the result is inconsistent with the clinical or radiological picture, the doctor usually recommends repeating the biopsy or further workup.
What to combine with
Good combinations
PSA and Prostate Health — An elevated or inconclusive PSA level after prostate imaging is one of the most common indications for a core-needle biopsy of the prostate gland
Liver Panel (ALT, AST, GGT, Bilirubin) — Chronically elevated liver enzymes unexplained by non-invasive workup are sometimes an indication for a liver biopsy
Complete Blood Count (CBC) — Blood-count abnormalities suggesting bone marrow disease are a typical indication for bone marrow aspiration and biopsy
Liver Elastography (FibroScan) — Liver elastography is sometimes used as a non-invasive alternative to, or a preceding step before, deciding on a liver biopsy
Safety
Side effects & contraindications
Possible side effects
Pain and tenderness at the puncture site, usually lasting a few days
A hematoma or minor bleeding at the biopsy site
Risk of pneumothorax with transthoracic lung biopsy — a significant proportion of cases require observation, less often drainage
Risk of infection at the puncture site
Rarely: damage to nearby structures (vessels, nerves, organs) depending on the lesion's location
Contraindications
Uncorrected clotting disorders or ongoing anticoagulant therapy that cannot be temporarily paused
No safe access route to the lesion, e.g., major vessels lying too close in a given location
Active skin infection at the planned puncture site
Inability of the patient to cooperate during a procedure requiring local anesthesia and maintaining a fixed position
Interactions
Anticoagulant and antiplatelet medications significantly raise bleeding risk and usually need to be temporarily stopped before the procedure
Uncorrected thrombocytopenia raises the risk of hemorrhagic complications regardless of medications used
A deep-seated, small lesion makes accurate needle placement harder, raising the risk of a non-diagnostic result and the need to repeat the procedure
Active immunosuppressive treatment raises the risk of infection at the biopsy site
Prior surgery or scarring near the planned access site may require changing the technique or approach route
Significant obesity hampers precise imaging and needle guidance, extending procedure time
Is it worth taking?
Who it's for
- People with a suspicious focal lesion found on imaging requiring histopathological confirmation
- Patients with abnormal lab results suggesting disease of a specific organ
- People with a skin lesion raising suspicion of a malignancy
- Cancer patients requiring determination of the subtype and molecular features of a tumor to choose targeted therapy
Not for
- Uncorrected clotting disorders or ongoing anticoagulant therapy that cannot be temporarily paused
- No safe access route to the lesion, e.g., major vessels lying too close in a given location
- Active skin infection at the planned puncture site
- Inability of the patient to cooperate during a procedure requiring local anesthesia and maintaining a fixed position
Evidence
Worth knowing
A core-needle biopsy preserves tissue architecture, distinguishing it from a fine-needle biopsy limited to cytological evaluation of individual cells.
Standard histopathological processing usually takes 24–48 hours, and additional testing (immunohistochemistry, molecular tests) extends the wait for a full result to several days to two weeks.
The complication rate of percutaneous biopsy varies significantly by organ and technique — it's notably higher for lung biopsy than for superficial-tissue biopsy.
Assessment of hormone receptors and molecular features from biopsy material directly determines the choice of targeted therapy in oncology today.
Studies
The diagnostic accuracy of core-needle biopsy compared with the final result after surgical excision reached 90.4%, though in a subset of patients final classification of the lesion still required surgical excision.
Tariq MU et al., Cureus, 2024
Complication rates of CT-guided transthoracic lung biopsy: meta-analysis
Strong evidenceHeerink WJ, de Bock GH, de Jonge GJ, Groen HJM, Vliegenthart R, Oudkerk M · European Radiology · 2017
A meta-analysis of 32 studies covering over 8,000 procedures assessing the complication rate of core-needle and fine-needle lung biopsy under CT guidance.
View studyAccuracy and Comparison of Core Needle Biopsy Diagnoses With Excision Specimen for Diagnosing Fibroepithelial Lesions of the Breast
Moderate evidenceTariq MU, Rani A, Kayani N, Sattar AK, Vohra L, Idress R · Cureus · 2024
An analysis of the agreement between core-needle biopsy diagnoses and the final result after surgical excision in patients with fibroepithelial breast lesions.
View studySources & bibliography
The PubMed identifiers in this knowledge base were checked against NCBI records (October 2026). If you spot an error in a source, please let us know via the contact form.
Compare with similar entries
About the authors of this entry
Author
Redakcja VitMode — Badania i biomarkeryEditorial team
VitMode Editorial — Lab Tests and Biomarkers is the VitMode editorial team responsible for: laboratory tests, interpreting results and ageing biomarkers. The team has no individual bylines — texts are prepared by VitMode editors from primary sources (clinical trials, meta-analyses, guidelines). Every cited PubMed paper is automatically checked for a matching identifier, title and publication year. The content is educational and does not replace medical advice. Factual errors can be reported in a comment under the post or through the contact form; corrections are made by the editorial team.
272 publications on this site
Editorial review
Redakcja VitMode — Hormony i endokrynologiaEditorial team
VitMode Editorial — Hormones and Endocrinology is the VitMode editorial team responsible for: hormones, testosterone therapy, the thyroid and metabolism. The team has no individual bylines — texts are prepared by VitMode editors from primary sources (clinical trials, meta-analyses, guidelines). Every cited PubMed paper is automatically checked for a matching identifier, title and publication year. The content is educational and does not replace medical advice. Factual errors can be reported in a comment under the post or through the contact form; corrections are made by the editorial team.
328 publications on this site
Related entries
PSA and Prostate Health
Prostate-specific antigen is one of the most commonly ordered tests in men over 50 — but also one of the most controversial, due to a high false-positive rate.
Liver Panel (ALT, AST, GGT, Bilirubin)
Four entries on a lab printout — ALT, AST, GGT, and bilirubin — can reveal liver damage before any symptoms appear, as long as you know how to tell a hepatocellular pattern apart from a cholestatic one.
Complete Blood Count (CBC)
The most commonly ordered laboratory test in the world — a seemingly simple printout hides information about immunity, oxygen transport, and blood clotting, if you know what to look for.
Liver Elastography (FibroScan)
Liver elastography (FibroScan) is a non-invasive ultrasound-based test measuring the stiffness of liver tissue, an indirect indicator of the degree of liver fibrosis. Unlike a biopsy, it doesn't require puncturing the organ, the result is available immediately, and the test can be safely repeated to monitor disease progression over time.
VO2 max
The maximum amount of oxygen the body can take up during exercise — one of the strongest, well-documented predictors of lifespan, measurable in a sports diagnostics lab.
MRI (Magnetic Resonance Imaging)
MRI uses a strong magnetic field and radio waves, not ionizing radiation, to produce images with exceptionally high soft-tissue contrast — brain, spinal cord, joints, and internal organs — at the cost of a much longer scan time than CT.
Mammography
An X-ray examination of the breast that is the primary method for screening detection of breast cancer at an early, asymptomatic stage — the only imaging test with mortality reduction documented in randomized clinical trials.
Echocardiography (Cardiac Echo)
Echocardiography is a real-time ultrasound test of the heart that — unlike an ECG, which only assesses electrical activity — shows chamber structure, valve function, and the strength of the heart muscle's contraction, with no radiation exposure.
Related articles
PoradnikiSjögren's Syndrome: Symptoms, Diagnosis, and Treatment
Sjögren's syndrome is a chronic autoimmune disease in which the immune system attacks the tear and salivary glands, causing persistent dry eyes and dry mouth. Though often dismissed as 'just dryness,' in some patients it involves other organs and carries an elevated lymphoma risk. We explain the disease mechanism, the 2016 ACR/EULAR diagnostic criteria, and the available symptomatic and immunomodulatory treatment options.
September 21, 2026
PoradnikiLiver Cirrhosis: Causes, Symptoms, and Stages of the Disease
Liver cirrhosis is the end stage of many different chronic liver diseases — not just alcohol misuse, though that association still dominates public perception. We explain the real causes of cirrhosis, why the distinction between compensated and decompensated disease is fundamental to prognosis, and which symptoms should prompt urgent medical attention.
September 21, 2026
PoradnikiNonalcoholic Fatty Liver Disease (NAFLD/MASLD): Overview, Diagnosis, and Treatment
Nonalcoholic fatty liver disease, now increasingly called MASLD, affects roughly a third of the world's adult population according to recent meta-analyses — yet most people don't know they have it, since the disease is typically silent for years. We explain how it's diagnosed, why it progresses to more serious liver inflammation (NASH/MASH) in some patients, and why weight loss remains the first-line treatment.
September 21, 2026
PoradnikiFibrocystic Breast Changes: Causes and Management
Tenderness, lumpiness, and a "grainy" feeling in the breasts just before a period affects up to 90% of women at some point in their lives — a phenomenon common enough that medicine long ago stopped calling it a disease. Fibrocystic breast changes (today more often called simply fibrocystic changes rather than "fibrocystic breast disease") don't themselves raise breast-cancer risk, but they can be a source of real discomfort and anxiety, especially when a new, palpable lump appears. We explain the hormonal mechanism behind these changes, what actually helps ease symptoms versus what's a myth, and when a breast lump needs urgent evaluation.
September 16, 2026
PoradnikiDifficulty Swallowing (Dysphagia): Causes, Tests and When to See a Doctor Urgently
Dysphagia is the sense that food or liquid does not pass smoothly from the mouth to the stomach. A distinction is made between oropharyngeal dysphagia (trouble starting a swallow, coughing and choking) and oesophageal dysphagia (a feeling of food sticking after swallowing), and the causes range from reflux and strictures, through eosinophilic oesophagitis and achalasia, to neurological disease and cancer. We explain how to tell the two types apart, which tests are done and which symptoms call for prompt investigation.
October 29, 2026
PoradnikiBlood in semen (hematospermia): causes and when to get tested
Blood in semen is usually benign and self-limiting, especially in men under forty, but it is understandably alarming and is often the first reason for a visit to a urologist. In a large American analysis of insurance claims data, among 56,157 men with benign hematospermia a urological cancer was diagnosed in 47, and among men under 40 in one out of 15,106. We explain the commonest causes (including prostate biopsy and infections), which tests are done first, when further work-up is justified and what the warning signs mean.
October 26, 2026
PoradnikiPhimosis in adults: causes, topical steroid treatment and when circumcision
In an adult man an inability to retract the foreskin is usually pathological phimosis, that is, the result of scarring, most often in lichen sclerosus (BXO), recurrent inflammation of the glans and foreskin, or diabetes. A topical steroid is often the first step, but the evidence is two-sided: in a Cochrane review for boys (14 trials, 1,459 patients) steroids increased complete resolution of phimosis (RR 2.73) with low certainty, while good-quality trials in adults are lacking. We explain how to tell physiological from pathological phimosis, when a biopsy is needed, how preputioplasty differs from circumcision and why paraphimosis is an emergency.
October 26, 2026
PoradnikiFIB-4 and Other Liver Fibrosis Scores Without a Biopsy: How to Read the Result
Liver fibrosis, the scarring that develops in the organ after long-term injury, gives no symptoms for a long time — and it, not steatosis itself, determines the risk of cirrhosis. A biopsy is no longer needed for a first assessment: age, two liver enzymes and the platelet count are enough to calculate the FIB-4 index. We explain the formula, the 1.3 and 2.67 cut-offs, why the result must be read differently in young people and after age 65, how FIB-4 combines with the ELF test and elastography in two-step pathways, what its limitations are (including in people with diabetes) and when to be referred to a hepatologist.
October 22, 2026